DK3577A - Fremgangsmade til fremstilling af anestetisk virksomme steroider - Google Patents
Fremgangsmade til fremstilling af anestetisk virksomme steroiderInfo
- Publication number
- DK3577A DK3577A DK3577A DK3577A DK3577A DK 3577 A DK3577 A DK 3577A DK 3577 A DK3577 A DK 3577A DK 3577 A DK3577 A DK 3577A DK 3577 A DK3577 A DK 3577A
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- preparation
- anesthetically effective
- effective steroids
- steroids
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB357/76A GB1570394A (en) | 1976-01-06 | 1976-01-06 | 11-acyloxy-3-hydroxy steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3577A true DK3577A (da) | 1977-07-07 |
Family
ID=9702974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK3577A DK3577A (da) | 1976-01-06 | 1977-01-05 | Fremgangsmade til fremstilling af anestetisk virksomme steroider |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5285159A (en:Method) |
| AU (1) | AU513579B2 (en:Method) |
| BE (1) | BE850108A (en:Method) |
| CA (1) | CA1084903A (en:Method) |
| DE (1) | DE2700267A1 (en:Method) |
| DK (1) | DK3577A (en:Method) |
| FR (1) | FR2361419A1 (en:Method) |
| GB (1) | GB1570394A (en:Method) |
| NL (1) | NL7700054A (en:Method) |
| NZ (1) | NZ183004A (en:Method) |
| SE (1) | SE7700098L (en:Method) |
| ZA (1) | ZA7759B (en:Method) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ300694A3 (en) * | 1993-12-02 | 1996-05-15 | Akzo Nobel Nv | Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof |
| GB0105772D0 (en) * | 2001-03-08 | 2001-04-25 | Sterix Ltd | Use |
| ES2738526T3 (es) | 2011-10-14 | 2020-01-23 | Sage Therapeutics Inc | Compuestos 19-norpregnano 3,3-disustituidos, composiciones y usos de los mismos |
| NZ773177A (en) | 2012-01-23 | 2022-09-30 | Sage Therapeutics Inc | Neuroactive steroid formulations and methods of treating cns disorders |
| IL275725B (en) | 2012-08-21 | 2022-08-01 | Sage Therapeutics Inc | Treatment methods for epilepsy and status epilepticus |
| AU2014256229B2 (en) | 2013-04-17 | 2018-10-04 | Sage Therapeutics, Inc. | 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof |
| RS60420B1 (sr) | 2013-04-17 | 2020-07-31 | Sage Therapeutics Inc | 19-nor neuroaktivni steroidi za metode lečenja |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| PL3021852T3 (pl) * | 2013-07-19 | 2021-07-05 | Sage Therapeutics, Inc. | Neuroaktywne steroidy, kompozycje i ich zastosowania |
| JP6466942B2 (ja) | 2013-08-23 | 2019-02-06 | セージ セラピューティクス， インコーポレイテッド | 向神経活性ステロイド、組成物、及びその使用 |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| HUE051488T2 (hu) | 2014-10-16 | 2021-03-01 | Sage Therapeutics Inc | Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére |
| WO2016061527A1 (en) | 2014-10-16 | 2016-04-21 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| US10774108B2 (en) | 2014-11-27 | 2020-09-15 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| PL3250210T3 (pl) | 2015-01-26 | 2021-07-26 | Sage Therapeutics, Inc. | Kompozycje i sposoby leczenia zaburzeń OUN |
| JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| EP4509079A3 (en) | 2015-06-10 | 2025-04-23 | Boston Scientific Scimed, Inc. | Bodily substance detection by evaluating photoluminescent response to excitation radiation |
| WO2017156103A1 (en) | 2016-03-08 | 2017-09-14 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JP7049313B2 (ja) | 2016-07-11 | 2022-04-06 | セージ セラピューティクス， インコーポレイテッド | Ｃ１７、ｃ２０、およびｃ２１置換神経刺激性ステロイドおよびそれらの使用方法 |
| ES2992037T3 (es) | 2016-07-11 | 2024-12-05 | Sage Therapeutics Inc | Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización |
| AR114044A1 (es) * | 2017-12-22 | 2020-07-15 | Sage Therapeutics Inc | Composiciones y métodos para el tratamiento de trastornos en el sistema nervioso central |
| TWI874337B (zh) | 2018-12-05 | 2025-03-01 | 美商賽吉醫療公司 | 神經活性類固醇及其使用方法 |
| CR20240234A (es) | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629) |
| KR20220038681A (ko) * | 2019-06-27 | 2022-03-29 | 세이지 테라퓨틱스, 인크. | Cns 장애를 치료하기 위한 조성물 및 방법 |
| CA3143545A1 (en) * | 2019-06-27 | 2020-12-30 | Sage Therapeutics, Inc. | Compounds for treating cns disorders |
-
1976
- 1976-01-06 GB GB357/76A patent/GB1570394A/en not_active Expired
-
1977
- 1977-01-05 BE BE173855A patent/BE850108A/xx not_active IP Right Cessation
- 1977-01-05 FR FR7700171A patent/FR2361419A1/fr active Granted
- 1977-01-05 AU AU21065/77A patent/AU513579B2/en not_active Expired
- 1977-01-05 CA CA269,161A patent/CA1084903A/en not_active Expired
- 1977-01-05 JP JP30477A patent/JPS5285159A/ja active Pending
- 1977-01-05 ZA ZA00770059A patent/ZA7759B/xx unknown
- 1977-01-05 DK DK3577A patent/DK3577A/da not_active Application Discontinuation
- 1977-01-05 SE SE7700098A patent/SE7700098L/ not_active Application Discontinuation
- 1977-01-05 NL NL7700054A patent/NL7700054A/xx not_active Application Discontinuation
- 1977-01-05 DE DE19772700267 patent/DE2700267A1/de not_active Ceased
- 1977-01-06 NZ NZ183004A patent/NZ183004A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE850108A (fr) | 1977-07-05 |
| DE2700267A1 (de) | 1977-07-14 |
| AU2106577A (en) | 1978-07-13 |
| CA1084903A (en) | 1980-09-02 |
| FR2361419A1 (fr) | 1978-03-10 |
| SE7700098L (sv) | 1977-07-07 |
| FR2361419B1 (en:Method) | 1980-04-04 |
| AU513579B2 (en) | 1980-12-11 |
| JPS5285159A (en) | 1977-07-15 |
| ZA7759B (en) | 1978-02-22 |
| GB1570394A (en) | 1980-07-02 |
| NL7700054A (nl) | 1977-07-08 |
| NZ183004A (en) | 1980-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK148677A (da) | Fremgangsmade til fremstilling af anestetisk virksomme steroider | |
| DK3577A (da) | Fremgangsmade til fremstilling af anestetisk virksomme steroider | |
| DK30277A (da) | Fremgangsmade til fremstilling af substituerede phenylamidiner | |
| DK377A (da) | Fremgangsmade til fremstilling af n-phosphonomethyl-glycin | |
| DK244577A (da) | Fremgangsmade til fremstilling af hydantoinderivater | |
| DK276177A (da) | Fremgangsmade til fremstilling af gammapyron-forbindelser | |
| DK577977A (da) | Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler | |
| DK339677A (da) | Fremgangsmade til fremstilling af 2-benzylpyrrolidiner | |
| DK587077A (da) | Fremgangsmaade til fremstilling af estere | |
| DK144377A (da) | Fremgangsmade til fremstilling af acylcyanider | |
| DK233477A (da) | Fremgangsmade til fremstilling af antiotiske midler | |
| DK88777A (da) | Fremgangsmade til fremstilling af substituerede azapuriner | |
| DK271377A (da) | Fremgangsmade til fremstilling af substituerede arylacetamidocephalosporiner | |
| DK216977A (da) | Fremgangsmade til fremstilling af imidazobenzoxaziner | |
| DK144277A (da) | Fremgangsmade til fremstilling af acylcyanider | |
| DK575077A (da) | Fremgangsmaade til fremstilling af 0-alkylerede oximer | |
| DK195077A (da) | Fremgangsmade til fremstilling af benzodiazepiner | |
| DK73277A (da) | Fremgangsmaade til fremstilling af sulfonylbenzimidazoler | |
| DK575277A (da) | Fremgangsmaade til fremstilling af basisk substituerede 0-propyloximer | |
| DK438277A (da) | Fremgangsmaade til fremstilling af 9-chlorprednisoloner | |
| DK196577A (da) | Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester | |
| DK538977A (da) | Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron | |
| DK582177A (da) | Fremgangsmaade til fremstilling af halogenacylamider | |
| DK564977A (da) | Fremgangsmaade til fremstilling af antirhinovirusmidler | |
| DK338677A (da) | Frefmgangsmade til fremstilling af 3-alkoxycyproheptadiner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |